Background. We studied the effects of low density lipoprotein (LDL) on endothelium function. Methods and Results. Porcine epicardial and intramyocardial coronary arteries suspended in organ chambers for isometric tension recording were exposed to LDL for 2 hours and were then washed. In epicardial coronary arteries, oxidized LDL (30-300 ,ug/mI) but not native LDL or lysolecithin inhibited endothelium-dependent relaxations to serotonin, thrombin, and aggre-
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Felix C. Tanner, MD; Georg Noll, MD; Chantal M. Boulanger, PhD; and Thomas F. Liischer, MD Background. We studied the effects of low density lipoprotein (LDL) on endothelium function. Methods and Results. Porcine epicardial and intramyocardial coronary arteries suspended in organ chambers for isometric tension recording were exposed to LDL for 2 hours and were then washed. In epicardial coronary arteries, oxidized LDL (30-300 ,ug/mI) but not native LDL or lysolecithin inhibited endothelium-dependent relaxations to serotonin, thrombin, and aggregating platelets (5,000-75,000/,ul). Endothelium-dependent relaxations to bradykinin and A23187 and endothelium-independent relaxations to SIN-1 were unaffected by oxidized LDL. In intramyocardial coronary arteries, oxidized LDL had no appreciable effect on relaxations to serotonin. The effect of oxidized LDL on the response to serotonin in epicardial coronary arteries was completely prevented by dextran sulfate (10 jiglml). The inhibitory effect of oxidized LDL persisted in the presence of pertussis toxin. Similar to the lipoproteins, L-NG-monomethyl arginine (L-NMMA) reduced relaxations to serotonin but not to bradykinin in epicardial coronary arteries. In the presence of L-NMMA, oxidized LDL further reduced the response to serotonin. In arteries in which relaxations to serotonin were inhibited by oxidized LDL, L-arginine but not D-arginine induced a full relaxation. Pretreatment with L-arginine potentiated relaxations to serotonin in arteries exposed to oxidized LDL.
Conclusions. Thus, oxidized LDL activates the scavenger receptor on endothelial cells and inhibits the receptor-operated nitric oxide formation in epicardial but not in intramyocardial coronary arteries. The mechanism is not related to dysfunction of a G; protein but is related to a reduced intracellular availability of L-arginine. The reduced nitric oxide formation at sites of early atherosclerotic lesions may favor platelet aggregation and vasospasm, both of which are known clinical events in patients with coronary artery disease. (Circulation 1991; 83:2012 -2020 L ow density lipoproteins (LDLs) are a major risk factor for coronary artery disease.' Oxidized LDLs have a marked atherogenic potential: They are chemotactic for circulating monocytes, inhibit the motility of the generated macrophages, and are taken up by the latter, leading to the formation of foam cells.2 Monocytes,3 endothelial cells,4 and smooth muscle cells5 can oxidize LDLs; hence, they are present in atherosclerotic lesions. 6 in epicardial coronary arteries and in certain peripheral arteries,16 it rarely occurs in the microcirculation. Because all blood vessels are similarly exposed to circulating LDL, this suggests a heterogeneity in the vascular susceptibility to the atherogenic substance.
This study was designed 1) to investigate the effects of native and oxidized LDLs on endothelial function of porcine coronary arteries, 2) to compare the responses of epicardial and intramyocardial coronary arteries, and 3) to delineate the cellular mechanisms.
Methods

Preparation of Blood Vessels
Epicardial coronary arteries. Farm pigs (weights 20±5 kg) were anesthetized with ketamine (50 mg/kg i.m.) followed by pentobarbital sodium (12.5 mg/kg i.v.). Blood (200 ml) was collected from the left atrium for the preparation of platelets. 9 .0+1.9 nmol malondialdehyde equivalents/ml. Protocols All protocols in epicardial coronary arteries were performed in parallel; one vessel was exposed to one of the atherogenic substances, and the other was used as control. In intramyocardial coronary arteries, one vessel was used as control and was then exposed to LDL. To compare epicardial and intramyocardial coronary arteries, we obtained both types of vessels from the same animal. Oxidized and native LDLs were added to the organ chambers for 2 hours and then removed by changing the control solution several times. The functional properties of the vessels were examined 10 minutes after washing. Lysolecithin (10 ,ug/ml) was present in the organ chambers for 2 hours14 and was not removed to test the responses of the arteries.
The relaxations were examined during a contraction caused by the thromboxane analogue U46619
(2 x 10-9 M to 5 x 10-9 M). To obtain the same preconditions for endothelium-dependent relaxation of the treated vessel and the corresponding control, we matched the contractions to U46619 until they did not differ by more than 10%. In addition, these contractions were between 60% and 80% of the Serotonin (-log M) n=6 * Control * Ox LDL (300 ,glml) 10 9 8 Bradykinin (-log M) FIGURE 1. 
Drugs
The following drugs were used: D-arginine, L-arginine, 2,6-di-tert-butyl-p-cresol, copper chloride, dextran sulfate (MW=1,000,000), EDTA, thiobarbituric acid, trichloroacetic acid (Fluka, Buchs, Switzerland), bradykinin, A23187, thrombin (Sigma Chemical Co., St. Louis), L-N0-monomethyl arginine, pertussis toxin (Calbiochem, Lucerne, Switzerland), 5-hydroxytryptamine creatinine sulfate (Serva, Heidelberg, FRG), ketanserin (Janssen Pharmaceutical, Beerse, Belgium), SIN (Figure 1 and Table 1 ). Relaxations to thrombin ( Figure 2 and Table 1 ) and to aggregating platelets ( Figure 3 and Table 1 ) were also inhibited by oxidized LDL (300 and 100 ,ug/ml, respectively). The sensitivity (pD2) to these relaxing agonists remained the same in treated vessels and in controls. The endothelium-dependent relaxations to bradykinin ( Figure 1 and Table 1 ) and A23187 ( Figure 2 and Table 1 ) were unaffected by oxidized LDL at concentrations of 300 gg/ml.
INTRAMYOCARDIAL CORONARY ARTERIES. In contrast to epicardial coronary arteries, endotheliumdependent relaxations of intramyocardial coronary arteries to serotonin were unaffected by oxidized LDL (100 ,tg/ml; n=5; p=NS; Figure 4 ) and were also not significantly inhibited by high concentrations of oxidized LDL (300 ,ug/ml).
Endothelium-independent relaxations. Relaxations of arteries without endothelium to the nitric oxide donor SIN-1 were not different in rings exposed to Figure 5 ). In the absence of dextran sulfate, however, the maximal relaxation of treated vessels was inhibited (56±10%; p<0.05 versus control; n=5). Hence, dextran sulfate prevented the inhibiting effect of oxidized LDL on the relaxations to serotonin (p<0.01 versus vessels exposed to oxidized LDL in the absence of dextran sulfate). G PROTEINS. Pertussis toxin (100 ng/ml) reduced the maximal relaxation to serotonin (54±10%) compared with that in control (88+3%; p<0.01; n=8; Figure 6 ). When oxidized LDL was added to vessels treated with pertussis toxin, the relaxation was further inhibited (30+5%; p <0.05 versus pertussis toxin alone; n=8).
L-ARGININE PATHWAY. The maximal relaxation to serotonin was reduced by L-NMMA (52+9%; control: 88±3%; p<0.01; n=6). In the presence of L-NMMA, oxidized LDL caused a further inhibition (22±4%;p<0.01 versus L-NMMA alone; n=6; Figure 6 ).
L-Arginine (10-4 M) but not D-arginine relaxed vessels (from 60±7% to 79±5%) exposed to oxidized LDL (100 ,ug/ml) when added after serotonin (p<0.05 versus treated rings before addition of L-arginine; n=6; Figure ther relaxed these vessels to 87+3% (p<0.005 versus treated rings before addition of L-arginine; n=6).
After the addition of L-arginine (10-`M or 3 x 10M
), the relaxations induced by serotonin of vessels exposed to oxidized LDL were not significantly different from those of controls (88+3%; n =6; p=NS).
When L-arginine ( relaxations to serotonin in vessels exposed to oxidized LDL (p<0.05 versus treated vessels in the absence of L-arginine). L-Arginine did not affect relaxations of control vessels (n=5; NS).
LYSOLECITHIN. Lysolecithin (10 gg/ml) had no effect on endothelium-dependent relaxations to serotonin (maximal relaxation of controls, 96+5%; treated vessels, 98-+-4%; n=5; p=NS).
Native Low Density Lipoproteins Native LDL at a concentration of 300 ,ug/ml had no effect on endothelium-dependent relaxations to Serotonin (-log M) serotonin and bradykinin or on endothelium-independent relaxations to SIN-1 ( Table 2) . Discussion This study demonstrates that oxidized but not native LDL inhibited endothelium-dependent relaxations to serotonin, thrombin, and aggregating platelets in porcine epicardial coronary arteries, whereas the lipoproteins did not affect endothelium-dependent relaxations to serotonin in intramyocardial coronary arteries. Endothelium-dependent relaxations to bradykinin and to A23187 as well as endotheliumindependent relaxations to SIN-1 were unaffected by oxidized LDL in epicardial coronary arteries.
The inhibitory effect of oxidized LDL on endothelium-dependent relaxations could be due to a decreased synthesis or release of endothelium-derived relaxing factors or could be related to a reduced vascular responsiveness to these factors. The latter possibility can be excluded because endotheliumindependent relaxations to SIN-1 were not affected even by a high concentration of oxidized LDL. Because the potency of endothelium-dependent relaxations is influenced by the level of precontraction of the blood vessels, oxidized LDL could exert its inhibitory effect by increasing vascular contractility. This, however, can be excluded because the lipoproteins in porcine coronary arteries -in contrast to the rabbit femoral artery33-did not enhance contractions to potassium chloride or U46619 under our experimental conditions where oxidized LDL was washed before the experiment. Thus, oxidized LDL specifically interfered with endothelial function of porcine epicardial coronary arteries.
In contrast to the rabbit aorta,14 the inhibitory effect of oxidized LDL could not be mimicked by lysolecithin. However, it was completely prevented by dextran sulfate, which is a competitive antagonist of acetylated LDL for the scavenger receptor. 31, 32 The latter is present on endothelial cells34- 36 Serotonin (-log M) FIGURE 7. Plots of effect of L-arginine on endothelium-dependent relaxations to serotonin in vessels exposed to oxidized low density lipoprotein (Ox LDL; 100 g/gnl). L-Arginine relaxed arteries treated with oxidized LDL when added after serotonin. Under these circumstances, the degree of relaxation of vessels exposed to oxidized LDL was no longer different from controls despite the inhibited relaxation to serotonin in these vessels before the The same pattern of action of oxidized LDL and the inhibitors of endothelium-derived nitric oxide suggests that the lipoproteins specifically interfere with the activity of the L-arginine pathway during stimulation with certain agonists. Oxidized LDL could interfere with the activity of the nitric oxideforming enzyme, compete with L-arginine for the enzyme, or interfere with the receptor-mediated intracellular availability of L-arginine. Inhibition of the nitric oxide-forming enzyme can be excluded because L-arginine but not D-arginine fully relaxed vessels in which the relaxation to serotonin was inhibited by oxidized LDL, whereas the amino acid did not relax arteries when added after U46619 had caused contraction. Competitive inhibition is unlikely because the basal release-as estimated by the endothelium-dependent contraction to L-NMMA40 -was not affected by oxidized LDL and because the lipoproteins did not cause endothelium-dependent contractions by themselves. Thus, the most likely explanation for the effect of oxidized LDL is an interference with the receptor-mediated intracellular availability of L-arginine.27,41 Indeed, L-arginine added before serotonin potentiated relaxations to the monoamine in vessels exposed to oxidized LDL, whereas the response remained unaffected in controls. Oxidized LDL may interfere with the receptoroperated release of L-arginine from intracellular stores or the synthesis of the amino acid.4243 In line with that interpretation, the effect of oxidized LDL persisted in the presence of L-NMMA. Moreover, the inhibition of endothelium-dependent relaxations by high concentrations of the lipoproteins was stronger than that by L-NMMA. If oxidized LDL indeed interferes with the intracellular availability of L-arginine, a further inhibition of the response in the presence of a competitive antagonist is expected.
The inhibitory effect of oxidized LDL on the production of endothelium-derived nitric oxide most probably is involved in the pathogenesis of coronary artery disease. The reduced endothelium-dependent relaxations of hypercholesterolemic porcine coronary arteries may be related to an accumulation of oxidized LDL in the vessel wall because the same inhibitory pattern of relaxations to serotonin and bradykinin was obtained in vessels exposed to oxidized LDL and in hypercholesterolemic arteries. 44 The involvement of oxidized LDL is further supported by the fact that a decreased release of endothelium-derived relaxing factor accounts for the impaired endothelium-dependent relaxations in hypercholesterolemia.45 It The resistance of intramyocardial coronary arteries toward the effect of oxidized LDL may be related to a smaller number of scavenger receptors on endothelial cells compared with those on epicardial coronary arteries, to a different function of the receptor in small coronary arteries, or to the fact that the contribution of nitric oxide to endothelium-dependent relaxations is smaller in these microvessels. The lack of inhibition of endothelium-dependent relaxation in intramyocardial coronary arteries further supports the involvement of oxidized LDL in coronary artery disease. Indeed, the atherosclerotic process is restricted to epicardial coronary arteries. 47 Similarly, vasospastic and thrombotic events occur almost exclusively in large coronary arteries. They may be related to the reduced nitric oxide formation at sites where oxidized LDL accumulated in the vessel wall. Thus, oxidized LDL may not only play an important role in atherogenesis, but also promote clinical events like vasospasm and thrombus formation, both of which are well known in patients with coronary artery disease.
